Exane Derivatives’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-167
| Closed | -$85.2K | – | 967 |
|
|
2022
Q1 | $85.2K | Buy |
+167
| New | +$80.5K | 0.02% | 491 |
|
|
2021
Q4 | – | Sell |
-50
| Closed | -$19.5K | – | 1019 |
|
|
2021
Q3 | $19.5K | Sell |
50
-1,014
| -95% | -$420K | ﹤0.01% | 681 |
|
|
2021
Q2 | $445K | Buy |
1,064
+1,058
| +17,633% | +$422K | 0.1% | 208 |
|
|
2021
Q1 | $2.23K | Hold |
6
| – | – | ﹤0.01% | 673 |
|
|
2020
Q4 | $2.1K | Buy |
6
+3
| +100% | +$1.01K | ﹤0.01% | 621 |
|
|
2020
Q3 | $935 | Sell |
3
-1,767
| -100% | -$543K | ﹤0.01% | 623 |
|
|
2020
Q2 | $522K | Sell |
1,770
-2,860
| -62% | -$820K | 0.14% | 126 |
|
|
2020
Q1 | $1.15M | Buy |
4,630
+4,024
| +664% | +$1.11M | 0.32% | 75 |
|
|
2019
Q4 | $180K | Sell |
606
-2,304
| -79% | -$603K | 0.03% | 267 |
|
|
2019
Q3 | $632K | Buy |
+2,910
| New | +$702K | 0.11% | 143 |
|
|
2019
Q2 | – | Sell |
-4,176
| Closed | -$1.03M | – | 720 |
|
|
2019
Q1 | $1.03M | Sell |
4,176
-348
| -8% | -$88.7K | 0.2% | 110 |
|
|
2018
Q4 | $1.13M | Buy |
4,524
+2,909
| +180% | +$768K | 0.2% | 111 |
|
|
2018
Q3 | $429K | Sell |
1,615
-647
| -29% | -$168K | 0.08% | 171 |
|
|
2018
Q2 | $555K | Buy |
2,262
+1,775
| +364% | +$426K | 0.09% | 171 |
|
|
2018
Q1 | $106K | Buy |
487
+24
| +5% | +$5.48K | 0.02% | 295 |
|
|
2017
Q4 | $102K | Buy |
463
+460
| +15,333% | +$97.5K | 0.02% | 296 |
|
|
2017
Q3 | $587 | Sell |
3
-2
| -40% | -$386 | ﹤0.01% | 472 |
|
|
2017
Q2 | $927 | Buy |
5
+1
| +25% | +$175 | ﹤0.01% | 480 |
|
|
2017
Q1 | $656 | Sell |
4
-24,843
| -100% | -$4.07M | ﹤0.01% | 424 |
|
|
2016
Q4 | $3.98M | Sell |
24,847
-34,998
| -58% | -$5.23M | 0.78% | 37 |
|
|
2016
Q3 | $8.38M | Sell |
59,845
-29,854
| -33% | -$4.18M | 1.26% | 14 |
|
|
2016
Q2 | $12.7M | Buy |
89,699
+89,696
| +2,989,867% | +$12M | 2.09% | 10 |
|
|
2016
Q1 | $387 | Hold |
3
| – | – | ﹤0.01% | 489 |
|
|
2015
Q4 | $353 | Hold |
3
| – | – | ﹤0.01% | 423 |
|
|
2015
Q3 | $348 | Hold |
3
| – | – | ﹤0.01% | 454 |
|
|
2015
Q2 | $366 | Hold |
3
| – | – | ﹤0.01% | 465 |
|
|
2015
Q1 | $355 | Sell |
3
-129,573
| -100% | -$14.4M | ﹤0.01% | 469 |
|
|
2014
Q4 | $13.1M | Buy |
+129,576
| New | +$12.3M | 1.82% | 15 |
|
Other funds holding UNH
Exane Derivatives's UNH Position: Q2 2022 in Review
Exane Derivatives sold out of UnitedHealth (UNH) in Q2 2022, closing a stake of 167 shares — an estimated $85.2K sold.
Exane Derivatives first reported a position in UNH in Q4 2014 and held it in 28 quarters. The position peaked at $13.1M in Q4 2014. 2,959 funds tracked by Wall St. Rank hold UNH as of Q2 2022.
- Exane Derivatives reported no remaining UnitedHealth position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 167 UnitedHealth shares in Q2 2022, an estimated $85.2K.
- Exane Derivatives first reported a position in UnitedHealth in Q4 2014 and held it in 28 quarters.
- Exane Derivatives's UnitedHealth position peaked at $13.1M in Q4 2014.
- 2,959 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.